- Home
- CTNM vs CHSCN Comparison
CTNM vs CHSCN Comparison
Compare CTNM & CHSCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- CHSCN
- Stock Information
- Founded
- CTNM 2009
- CHSCN N/A
- Country
- CTNM United States
- CHSCN United States
- Employees
- CTNM N/A
- CHSCN N/A
- Industry
- CTNM
- CHSCN Farming/Seeds/Milling
- Sector
- CTNM
- CHSCN Industrials
- Exchange
- CTNM Nasdaq
- CHSCN Nasdaq
- Market Cap
- CTNM 114.1M
- CHSCN N/A
- IPO Year
- CTNM 2024
- CHSCN N/A
- Fundamental
- Price
- CTNM $3.87
- CHSCN $25.13
- Analyst Decision
- CTNM Strong Buy
- CHSCN
- Analyst Count
- CTNM 4
- CHSCN 0
- Target Price
- CTNM $23.75
- CHSCN N/A
- AVG Volume (30 Days)
- CTNM 86.8K
- CHSCN N/A
- Earning Date
- CTNM 05-16-2025
- CHSCN N/A
- Dividend Yield
- CTNM N/A
- CHSCN N/A
- EPS Growth
- CTNM N/A
- CHSCN N/A
- EPS
- CTNM N/A
- CHSCN N/A
- Revenue
- CTNM N/A
- CHSCN N/A
- Revenue This Year
- CTNM N/A
- CHSCN N/A
- Revenue Next Year
- CTNM N/A
- CHSCN N/A
- P/E Ratio
- CTNM N/A
- CHSCN N/A
- Revenue Growth
- CTNM N/A
- CHSCN N/A
- 52 Week Low
- CTNM $3.69
- CHSCN N/A
- 52 Week High
- CTNM $22.00
- CHSCN N/A
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- CHSCN 49.90
- Support Level
- CTNM N/A
- CHSCN $25.17
- Resistance Level
- CTNM N/A
- CHSCN $25.36
- Average True Range (ATR)
- CTNM 0.00
- CHSCN 0.14
- MACD
- CTNM 0.00
- CHSCN 0.02
- Stochastic Oscillator
- CTNM 0.00
- CHSCN 54.18
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About CHSCN CHS Inc Preferred Class B Series 2 Reset Rate
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).